Cargando…
Xuesaitong Combined with Dexmedetomidine Improves Cerebral Ischemia-Reperfusion Injury in Rats by Activating Keap1/Nrf2 Signaling and Mitophagy in Hippocampal Tissue
Ischemic stroke is the most common type of cerebrovascular disease with high mortality and poor prognosis, and cerebral ischemia-reperfusion (CI/R) injury is the main murderer. Here, we attempted to explore the effects and mechanism of Xuesaitong (XST) combined with dexmedetomidine (Dex) on CI/R inj...
Autores principales: | Han, Guo-Jie, Min, Xiang-Zhen, Ma, Shuang-Shuang, Ding, Chuan, Wang, Xiu-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750788/ https://www.ncbi.nlm.nih.gov/pubmed/36531207 http://dx.doi.org/10.1155/2022/5126042 |
Ejemplares similares
-
Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury
por: Shen, Luoan, et al.
Publicado: (2021) -
Role of Keap1-Nrf2/ARE signal transduction pathway in protection of dexmedetomidine preconditioning against myocardial ischemia/reperfusion injury
por: Li, Hui-xian, et al.
Publicado: (2022) -
Electroacupuncture Pretreatment against Cerebral Ischemia/Reperfusion Injury through Mitophagy
por: Mao, Chenlu, et al.
Publicado: (2020) -
Pharmacological Protection against Ischemia-Reperfusion Injury by Regulating the Nrf2-Keap1-ARE Signaling Pathway
por: Ucar, Bercis Imge, et al.
Publicado: (2021) -
Protective Effects of Dexmedetomidine and Oxycodone in Patients Undergoing Limb Ischemia-Reperfusion
por: Cheng, Wenjie, et al.
Publicado: (2019)